Results 301 to 310 of about 2,149,829 (345)
Some of the next articles are maybe not open access.

Reassessing the optimal volume for malignancy detection in serous fluid cytology

Cancer Cytopathology, 2022
The international system for reporting serous fluid cytopathology (TIS) recommends submitting at least 50‐75 mL of serous fluid to decrease false‐negative results. However, prior studies did not agree on specific volume requirements or consensus adequacy
Daniel Martínez Coconubo   +5 more
semanticscholar   +1 more source

A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience

Acta Cytologica, 2022
Introduction: The International Academy of Cytology and the American Society of Cytopathology recently proposed the International System for Reporting Serous Fluid Cytology (ISRSFC) to standardize serous fluid cytopathology reporting and guide further ...
P. Rajeswaran   +3 more
semanticscholar   +1 more source

Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies

Cancer Cytopathology, 2022
The International System for Reporting Serous Fluid Cytopathology (ISRSFC) was published recently to provide standard reporting terminology for serous fluid.
T. Sun, Minhua Wang, He Wang
semanticscholar   +1 more source

Categorisation of peritoneal serous effusions using the International System for Reporting Serous Fluid Cytopathology—A study on gynaecological samples

Cytopathology, 2022
Cytology of serous effusions is an indispensable diagnostic tool for the diagnosis of non‐neoplastic as well as neoplastic effusions, aiding in the categorisation, staging, and prognostication of the patient.
Garima Rakheja   +7 more
semanticscholar   +1 more source

Risk Stratification of Pleural Fluid Cytology Based on the International System for Reporting Serous Fluid Cytology in a Tertiary Care Centre

Acta Cytologica, 2022
Background: The International Academy of Cytology and the American Society of Cytopathology proposed the international system for reporting serous fluid cytology (TISRSFC) in 2019 to form uniform reporting terminologies for fluid cytology.
S. Bharti   +8 more
semanticscholar   +1 more source

Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy

Diagnostic Cytopathology, 2021
The International System for Reporting Serous Fluid Cytopathology (ISRSFC) was proposed by the International Academy of Cytology and the American Society of Cytopathology.
Shilpy Jha, Madhusmita Sethy, A. Adhya
semanticscholar   +1 more source

A retrospective analysis of pleural effusion specimens based on the newly proposed International System for Reporting Serous Fluid Cytopathology

Diagnostic Cytopathology, 2021
Recently, the International System for Reporting Serous Fluid Cytopathology (TIS) has been established, with an aim to standardize reporting and guide clinical decision making.
Yi Xu   +5 more
semanticscholar   +1 more source

Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy

Cytopathology, 2021
The International System for Reporting Serous Fluid Cytopathology (ISRSFC) standardises the reporting of serous effusion cytology under five categories: Non‐Diagnostic (ND), Negative for Malignancy (NFM), Atypia of Undetermined Significance (AUS ...
S. Ahuja, A. Malviya
semanticscholar   +1 more source

Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center

Diagnostic Cytopathology, 2020
Cytological analysis is part of the initial etiological evaluation of serous effusions. The newly proposed International System for Reporting Serous Fluid Cytopathology (ISRSFC) aims to standardize reporting.
C. Lobo   +5 more
semanticscholar   +1 more source

Ancillary Studies for Serous Fluids

2020
Spread of malignancies to serous cavities represents advanced stage disease that necessitates systemic treatment. Immunochemistry (IC) is an indispensable tool to ascertain malignancy in equivocal cases and to define the histological subtype or primary site of a metastatic tumor.
Bubendorf, Lukas   +6 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy